Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over 12,000 men in Sweden.

Hormone therapy initiation depends on disease extent; some agents avoid testosterone flare, allowing ADT without Casodex in certain cases. Active surveillance is increasingly chosen for favorable ...

PET scan changed treatment plans for nearly half of patients whose first scan was negative, according to new research ...

A new means of prostate cancer screening could emerge as an alternative to the PSA test, which has long been the first-line option. Using machine learning, a form of artificial intelligence, Swedish ...

In a population-based cohort study, a single prostate-specific antigen (PSA) measurement in men aged 45-70 years effectively identified individuals with low risk for cancer. Men with PSA levels < 1.00 ...

Biochemical recurrence is when your PSA level starts to rise after finishing prostate cancer treatment, and it may sometimes indicate metastatic disease. Biochemical recurrence is a term for when your ...

A large analysis suggests that a multivariable risk assessment tool, called Stockholm3, can detect substantially more ...

Fréquent mais longtemps silencieux, le cancer de la prostate interroge les hommes dès la cinquantaine. À quel âge parler du ...

Prostate cancer is the most common cancer in Australia, with about 26,000 men diagnosed per year. The majority (more than 85%) are aged over 60. Prostate cancer kills around 3,900 Australians a year.

Here’s a PSA about PSA—meaning a public service announcement about prostate specific antigen. Although checking the PSA levels in your blood is a routine way of screening for prostate cancer, just ...

Researchers at the University of British Columbia have identified a new form of hereditary prostate cancer that, while rare, ...

Les immunothérapies contre le cancer sont une stratégie prometteuse, mais souvent freinée par une toxicité parfois sévère.